Inter-country workshop on Causality Assessment of AEFI
18 – 20 February 2014 Bangkok
31 participants from Bangladesh, Bhutan, India, Indonesia, Maldives, Nepal, Sri Lanka, Thailand, Timor Leste and Vietnam participated in the first inter-country workshop that provided “hands on” training on the Revised WHO causality assessment methodology using cases from participating countries. Participants included EPI program managers, Epidemiologists, National Regulatory Authorities, clinical specialists, representatives from National Control Laboratories, National AEFI committees, Ministry of Health and WHO country office vaccine safety focal persons.
The workshop built national and regional capacity to investigate AEFI, assess causality, streamline AEFI data collection procedures and encouraged regional and global collaboration.
CIOMS Working Group on Vaccine Safety
The third meeting of the CIOMS working group on vaccine safety took place on 5-6 February 2014 in Atlanta. The meeting that was hosted by the US CDC, gathered 19 members from regulatory agencies, public health agencies, pharmaceutical companies and the WHO collaborating centre for international drug monitoring. The objective of the meeting was for members to agree upon the scope of work and to develop a work plan. The group decided to focus its efforts on three main topics:
1. Concepts for assessing pre and post-licensing vaccine safety information
2. Guidance for vaccine safety active surveillance
3. Guidance for vaccine safety crisis management.
The working group is expected to produce a series of consensus publications on the above topics.
In follow up of the last GVSI meeting held in November 2013, the 4th GVSI bulletin is now available online. It includes a regional report on vaccine safety activities in Africa, summaries of GVSI stakeholders’ activities, and provides information from the Report on Safety of Immunization during Pregnancy from the Global Advisory Committee on Vaccine Safety.
The second Global Vaccine Safety meeting took place in New Delhi, India on 19-20 November 2013
This meeting guides the Global Vaccine Safety Initiative (GVSI), which is the implementation mechanism for the Global Vaccine Safety Blueprint.
During two days, immunization programme managers and national regulatory authorities pharmacovigilance staff from twenty one countries gathered with representatives from UN agencies, academic institutions, pharmaceutical companies umbrella organizations, partner and funding agencies. Participants interacted and exchanged information on progress with implementation of national and global vaccine pharmacovigilance and identified needs and opportunities for further development.
- The Global Vaccine Safety Initiative (GVSI)
- Global Vaccine Safety Blueprint
- Strategic Advisory Group of Experts (SAGE) on Immunization
- The Decade of Vaccine - Global Vaccine Action Plan
- Global Vaccine Safety Blueprint - landscape analysis
Global Vaccine Safety initiative activities portfolio 2012-2020